Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
850.00    34.00 (4.17%)
Bid:
844.00
Ask:
852.00
Spread: 8.00 (0.948%)
Market Cap: £391.82m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Director/PDMR Shareholding

13 Feb 2026 16:15

RNS Number : 0141T
Porvair PLC
13 February 2026
Β 

13 February 2026

Β 

Β 

Porvair plc

("Porvair" or the "Group" or the "Company")

Β 

Director/PDMR Shareholding

The Company announces that on 11 February 2026 options were granted under the Group's Long Term Share Plan 2018 ("LTSP") to the Executive Directors.Β Options under the LTSP were granted as follows:

Director

Position

Options awarded under the LTSP

Grant date

Vesting date

Minimum holding period

Total options held, including SAYE options

Hooman Caman Javvi

CEO

88,110

11 February 2026

11 February 2029

2 years after vesting

216,751

James Mills

CFO

59,680

297,931

Β 

These options, with aΒ 2 penceΒ exercise price, can only be exercised in full if the Remuneration Committee is satisfied that in the financial year ending 30 November 2028 ("FY2028") the Group has achieved Adjusted EPS of at leastΒ 64.3 pence, which is a 15% compound annual growth rate from the Adjusted EPS in the year ended 30 November 2025. 20% of the award will vest if the Group has achieved Adjusted EPS ofΒ 47.6 penceΒ in FY2028. A sliding scale will operate if Adjusted EPS are betweenΒ 47.6 penceΒ andΒ 64.3 pence. No shares vest if the Adjusted EPS in FY2028 is belowΒ 47.6 pence.

After the vesting period, before the end of the two-year holding period, the option holder may exercise the option but may only sell sufficient shares to settle the option price and the income tax payable.Β The options may be exercised after the vesting period up until 11 February 2036. Claw-back and malus provisions apply.

Following these grants, the total number of LTSP and SAYE options in issue is 871,643, representing approximately 1.8% of the shares in issue.

For further information, please contact:

Porvair plc

+44 (0)1553 765 500

Andrew Douglass, Group Company Secretary

Β 

Β 

Notes to editors

Β 

Porvair plc

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

Β 

The information below (set out in accordance with the requirements of the Market Abuse Regulation) provides further detail:

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Hooman Caman Javvi

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Options over Ordinary Shares ofΒ 2 penceΒ under the Porvair plc Long Term Share PlanΒ 

Β 

GB0006963689

b.

Nature of the transaction

Grant of options

Β 

c.

Price(s) and volume(s)

Β 

Price(s)

Β 

Volume(s)

n/a

88,110

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

Β 

n/a - single transaction

e.

Date of the transaction

11 February 2026

f.

Place of the transaction

Outside a trading venueΒ 

Β 

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

James Mills

2.

Reason for the notification

a.

Position/status

CFO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Options over Ordinary Shares ofΒ 2 penceΒ under the Porvair plc Long Term Share PlanΒ 

Β 

GB0006963689

b.

Nature of the transaction

Grant of options

Β 

c.

Price(s) and volume(s)

Β 

Price(s)

Β 

Volume(s)

n/a

59,680

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

Β 

n/a - single transaction

e.

Date of the transaction

11 February 2026

f.

Place of the transaction

Outside a trading venueΒ 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHKZGMZKFVGVZM
Date   Source Headline
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:35 pmRNSPrice Monitoring Extension
7th Sep 20226:05 pmRNSDirector/PDMR Shareholding
6th Sep 20224:40 pmRNSHolding(s) in Company
2nd Sep 20223:06 pmRNSHolding(s) in Company
10th Aug 20224:40 pmRNSSecond Price Monitoring Extn
10th Aug 20224:36 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSDirector Declaration
5th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSHalf Year Results 2022
30th Jun 20222:15 pmRNSDirector/PDMR Shareholding
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:36 pmRNSPrice Monitoring Extension
28th Apr 20227:00 amRNSDirector/PDMR Shareholding
14th Apr 20221:42 pmRNSAGM resolutions
14th Apr 20227:00 amRNSAGM Trading Update
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBlock listing Interim Review
28th Feb 20227:00 amRNSTotal Voting Rights
4th Feb 20223:00 pmRNSDirector/PDMR Shareholding
4th Feb 202212:20 pmRNSGrant of LTSP awards
3rd Feb 202211:27 amRNSDirector/PDMR Shareholding
31st Jan 20227:00 amRNSResults for the year ended 30 November 2021
14th Dec 202112:25 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.